摘要
体外膜肺氧合(ECMO)作为目前最高级的生命支持技术之一,可暂时替代患者心肺功能,为患者器官功能恢复争取宝贵时间。本文就体外膜肺氧合技术在儿科重症中的临床应用作一述评,并分析我国儿童ECMO发展的制约因素,希望中国儿科ECMO技术快速发展,进一步发挥对危重患儿的救治作用。
Extracorporeal membrane oxygenation(ECMO)is one of the most advanced life support technology,which provides temporary cardiopulmonary support and earns precious time for patients organ function recovery.In this paper,the application of ECMO in pediatric critical care medicine is introduced.The factors of restricting domestic ECMO technology development are also analyzed.We hope that the development of ECMO in pediatrics will be accelerated in China,and better use for the severe patients.
作者
刘成军
卢思为
LIU Chengjun;LU Siwei(Department of Critical Medicine,Children's Hospital, Chongqing Medical University, Chongqing 400014, China)
出处
《西部医学》
2020年第5期643-646,共4页
Medical Journal of West China
基金
重庆市技术创新与应用示范社会民生类一般项目(CSTC2018jsCT-msybx0126)。
关键词
体外膜肺氧合
生命支持
儿童重症医学
心肺功能
Extracorporeal membrane oxygenation
Life support
Pediatric critical care medicine
Heart and lung function